Finally, p16 over-expression is not synonymous with the presence of HPV-related cancer but studies that have demonstrated the utility of p16 as a surrogate marker for oncogenic-HPV infection, with up to 100% sensitivity and 93% specificity [23]. Here, CDKN2A is linked to cancer.